Sei Investments CO Cyma Bay Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $169,848 - $329,072	-13,448 Reduced 15.93%	70,972 $1.68 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $309,998 - $502,962	28,545 Added 51.09%	84,420 $1.26 Million
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $417,386 - $611,831	55,875 New	55,875 $611,000
Q4 2019 Feb 06, 2020	BUY	$1.33 - $5.93 $83,623 - $372,848	62,875 New	62,875 $123,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.